Stock Taper 
ABT
$111.14
▲ UP 2.02% (2.21)
KEY STATISTICS
Market Cap$188.40 B
52w High$137.49
52w Low$81.97
Dividend Yield2.66%
FrequencyQuarterly
P/E21.33
Volume4.44M
Shares Out.1.73B
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Robert Ford
COMPENSATION 2026
Salary$1,500,000
Stock Awards$8,787,378
Incentive Plan Pay$1,968,750
All Other Comp.$959,798
Total$23,173,052
ABOUT
SECTOR
Healthcare
WENT PUBLIC
March 17, 1980
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
115,000
PRICE TARGET
Target High$145.00
Target Low$92.00
Target Median$121.00
Target Consensus$123.64
UPCOMING EARNINGS
DateOct 21, 2026
DayWednesday
Rev. Est.$12.99B
OCT
21
WED
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2013-01-02 | Forward | 5000:2399 |
| 2004-05-03 | Forward | 2500:2339 |
| 1998-06-01 | Forward | 2:1 |
| 1992-06-01 | Forward | 2:1 |
| 1990-06-01 | Forward | 2:1 |
| 1986-06-02 | Forward | 2:1 |
| 1981-06-01 | Forward | 2:1 |
| 1978-05-23 | Forward | 2:1 |
| 1975-08-25 | Forward | 2:1 |
PRICE
$111.14 ▲ UP 2.02% (+$2.21)About Abbott Laboratories
https://www.abbott.com ↗Abbott Laboratories develops, manufactures, and sells global healthcare products across pharmaceuticals, diagnostics, nutrition, and medical devices to improve health outcomes worldwide.
INDUSTRY
Medical - Devices
A PRODUCT ABBOTT LABORATORIES IS KNOWN FOR
FreeStyle Libre 3
Abbott's FreeStyle Libre 3 is the world's smallest, most advanced continuous glucose monitor, providing real-time, fingerstick-free glucose readings every minute via smartphone, showcasing Abbott’s leadership in diabetes innovation.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Medical Devices | $5.45B | $5.67B ▲ | $5.54B ▼ | $5.85B ▲ |
 | Diagnostic Products | $6B | $0 ▼ | $6.2B ▲ | $3.09B ▼ |
 | Nutritional Products | $2.15B | $1.94B ▼ | $2.02B ▲ | $2.14B ▲ |
 | Established Pharmaceutical Products | $1.51B | $1.38B ▼ | $1.43B ▲ | $1.5B ▲ |
 | Other | — | — | — | $5M |
Revenue by Geography
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | NonUS | $7.07B | $0 ▼ | $6.89B ▲ | $7.38B ▲ |
 | UNITED STATES | $4.3B | $4.38B ▲ | $4.27B ▼ | $5.22B ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
1,040
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
100.00%
HOLDERS
4,489
TOP 12 OF 4,489 · RANKED BY POSITION SIZE
Metatron Capital Sicav Plc
Vanguard Group Inc
Blackrock, Inc.
Blackrock Inc.
State Street Corp
Capital International Investors
Sixth Street Partners Management Company, L.P.
Charles Schwab Investment Management Inc
Capital Research Global Investors
Blackrock Institutional Trust Company, N.A.
J. Stern & Co. Llp
Geode Capital Management, LLC
RATINGS SNAPSHOT
Overall rating: B
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score3
TRADES BY CONGRESS
HOUSE TRADES
Laura Friedman
Exchange
2026-03-24
Richard Dean Dr McCormick
Purchase
2026-03-19
Rich McCormick
Purchase
2026-03-19
Michael McCaul
Sale
2026-03-04
INSIDER TRADES
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
Ford Robert B
Purchase · 247.0K shares
2026-08-25
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
Ford Robert B
Sale · 218.5K shares
2026-08-25
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
Ford Robert B
Sale · 180.3K shares
2026-08-25
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
Ford Robert B
Sale · 151.9K shares
2026-08-25
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 9
OUTPERFORM 6
OVERWEIGHT 4
19 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 MRK | $150.94 | COMPARE |
 UNH | $399.24 | COMPARE |
 NVS | $161.97 | COMPARE |
 TMO | $606.56 | COMPARE |
 NVO | $46.73 | COMPARE |
 GILD | $149.60 | COMPARE |
 ISRG | $370.69 | COMPARE |
 SYK | $314.31 | COMPARE |